Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an update.
Themis Medicare Limited announced significant changes in its leadership team, including the appointment of Ms. Neha Thakore as an Additional Non-Executive Woman Independent Director and Mr. Viraj Save as Executive President of Sales & Marketing. These appointments are expected to strengthen the company’s strategic direction and operational capabilities. Additionally, the company approved its un-audited financial results for the quarter ended June 30, 2025, and set a record date for determining the entitlement of members to receive the final dividend for the financial year ended March 31, 2025.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical industry, focusing on the production of Active Pharmaceutical Ingredients (APIs) and other pharmaceutical products. The company is engaged in strategic growth and manufacturing operations, with a commitment to sustainable practices and corporate governance.
Average Trading Volume: 16,949
Technical Sentiment Signal: Sell
Current Market Cap: 9.89B INR
For detailed information about THEMISMED stock, go to TipRanks’ Stock Analysis page.